124 related articles for article (PubMed ID: 18084763)
1. Cisplatin, gemcitabine and treosulfan is effective in chemotherapy-pretreated relapsed stage IV uveal melanoma patients.
Atzpodien J; Terfloth K; Fluck M; Reitz M
Cancer Chemother Pharmacol; 2008 Sep; 62(4):685-8. PubMed ID: 18084763
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patients.
Atzpodien J; Terfloth K; Fluck M; Reitz M
Br J Cancer; 2007 Nov; 97(10):1329-32. PubMed ID: 17971774
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of cisplatin, gemcitabine and treosulfan in patients with metastatic uveal melanoma.
Schmittel A; Scheulen ME; Bechrakis NE; Strumberg D; Baumgart J; Bornfeld N; Foerster MH; Thiel E; Keilholz U
Melanoma Res; 2005 Jun; 15(3):205-7. PubMed ID: 15917703
[TBL] [Abstract][Full Text] [Related]
4. Age has no significant impact on overall survival and on treatment tolerability in relapsed stage IV cutaneous malignant melanoma patients receiving Cisplatin, Gemcitabine, and Treosulfan.
Atzpodien J; Terfloth K; Fluck M; Reitz M
Am J Clin Oncol; 2011 Feb; 34(1):2-5. PubMed ID: 20042970
[TBL] [Abstract][Full Text] [Related]
5. A two-cohort phase II clinical trial of gemcitabine plus treosulfan in patients with metastatic uveal melanoma.
Schmittel A; Schuster R; Bechrakis NE; Siehl JM; Foerster MH; Thiel E; Keilholz U
Melanoma Res; 2005 Oct; 15(5):447-51. PubMed ID: 16179873
[TBL] [Abstract][Full Text] [Related]
6. A clinical phase I trial of gemcitabine and treosulfan in uveal melanoma and other solid tumours.
Keilholz U; Schuster R; Schmittel A; Bechrakis N; Siehl J; Foerster MH; Thiel E
Eur J Cancer; 2004 Sep; 40(14):2047-52. PubMed ID: 15341977
[TBL] [Abstract][Full Text] [Related]
7. Phase I trial combining gemcitabine and treosulfan in advanced cutaneous and uveal melanoma patients.
Corrie PG; Shaw J; Spanswick VJ; Sehmbi R; Jonson A; Mayer A; Bulusu R; Hartley JA; Cree IA
Br J Cancer; 2005 Jun; 92(11):1997-2003. PubMed ID: 15886706
[TBL] [Abstract][Full Text] [Related]
8. Treosulfan and gemcitabine in metastatic uveal melanoma patients: results of a multicenter feasibility study.
Pföhler C; Cree IA; Ugurel S; Kuwert C; Haass N; Neuber K; Hengge U; Corrie PG; Zutt M; Tilgen W; Reinhold U
Anticancer Drugs; 2003 Jun; 14(5):337-40. PubMed ID: 12782938
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of in vitro chemosensitivity testing: the example of uveal melanoma.
Terheyden P; Bröcker EB; Becker JC
J Cancer Res Clin Oncol; 2004 Jul; 130(7):395-9. PubMed ID: 15160290
[TBL] [Abstract][Full Text] [Related]
10. A randomized phase II trial of gemcitabine plus treosulfan versus treosulfan alone in patients with metastatic uveal melanoma.
Schmittel A; Schmidt-Hieber M; Martus P; Bechrakis NE; Schuster R; Siehl JM; Foerster MH; Thiel E; Keilholz U
Ann Oncol; 2006 Dec; 17(12):1826-9. PubMed ID: 16971664
[TBL] [Abstract][Full Text] [Related]
11. A prospective single arm phase II study of dacarbazine and treosulfan as first-line therapy in metastatic uveal melanoma.
O'Neill PA; Butt M; Eswar CV; Gillis P; Marshall E
Melanoma Res; 2006 Jun; 16(3):245-8. PubMed ID: 16718271
[TBL] [Abstract][Full Text] [Related]
12. Treosulfan and gemcitabine.
Cree IA; Neale MH; Reinhold U; Kurbacher CM
J Cancer Res Clin Oncol; 2005 May; 131(5):329-30; author reply 331. PubMed ID: 15700153
[No Abstract] [Full Text] [Related]
13. Phase II trial of 5-fluorouracil/leucovorin/gemcitabine/cisplatin as second-line treatment in patients with metastatic or recurrent colorectal carcinoma: a cancer therapeutics research group study.
Chang AY; Lopes G; Hsin KW; Lim R; Fong FK; Wong J
Clin Colorectal Cancer; 2007 Sep; 6(9):646-51. PubMed ID: 17945037
[TBL] [Abstract][Full Text] [Related]
14. Treosulfan in the treatment of metastatic melanoma: from chemosensitivity testing to clinical trials.
Neuber K
Recent Results Cancer Res; 2003; 161():159-79. PubMed ID: 12528807
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer: a phase II trial.
Laack E; Mende T; Dürk H; Kneba M; Dickgreber N; Welte T; Müller T; Scholtze J; Graeven U; Jasiewicz Y; Edler L; Hossfeld DK
Eur J Cancer; 2002 Mar; 38(5):654-60. PubMed ID: 11916547
[TBL] [Abstract][Full Text] [Related]
16. Second-line chemotherapy of metastatic malignant melanoma with intravenous treosulfan: a phase II multicentre trial.
Neuber K; Reinhold U; Deutschmann A; Pföhler C; Mohr P; Pichlmeier U; Baumgart J; Hauschild A
Melanoma Res; 2003 Feb; 13(1):81-5. PubMed ID: 12569289
[TBL] [Abstract][Full Text] [Related]
17. Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials.
Fang W; Yang Y; Ma Y; Hong S; Lin L; He X; Xiong J; Li P; Zhao H; Huang Y; Zhang Y; Chen L; Zhou N; Zhao Y; Hou X; Yang Q; Zhang L
Lancet Oncol; 2018 Oct; 19(10):1338-1350. PubMed ID: 30213452
[TBL] [Abstract][Full Text] [Related]
18. A randomized study comparing two different schedules of administration of cisplatin in combination with gemcitabine in advanced nonsmall cell lung carcinoma.
Ricci S; Antonuzzo A; Galli L; Tibaldi C; Bertuccelli M; Lopes Pegna A; Petruzzelli S; Bonifazi V; Orlandini C; Franco Conte P
Cancer; 2000 Oct; 89(8):1714-9. PubMed ID: 11042565
[TBL] [Abstract][Full Text] [Related]
19. A Phase II trial of erlotinib as maintenance treatment after gemcitabine plus platinum-based chemotherapy in patients with recurrent and/or metastatic nasopharyngeal carcinoma.
You B; Le Tourneau C; Chen EX; Wang L; Jarvi A; Bharadwaj RR; Kamel-Reid S; Perez-Ordonez B; Mann V; Siu LL
Am J Clin Oncol; 2012 Jun; 35(3):255-60. PubMed ID: 21358293
[TBL] [Abstract][Full Text] [Related]
20. [Phase II trial of prolonged infusion of low-dose gemcitabine in advanced non-small cell lung cancer treatment].
Xiong JP; Zhang L; Zhong LX; Qiu F; Guo YL; Lian HY; Luo H
Ai Zheng; 2006 Aug; 25(8):995-8. PubMed ID: 16965681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]